Jung Hyun Jo, M.D., M.Med., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biliary Tract Neoplasms | 6 | 2024 | 184 | 1.960 |
Why?
|
Cholestasis | 6 | 2023 | 377 | 1.570 |
Why?
|
Pancreatic Neoplasms | 18 | 2024 | 5348 | 1.500 |
Why?
|
Carcinoma, Pancreatic Ductal | 9 | 2024 | 1723 | 1.280 |
Why?
|
Bile Duct Neoplasms | 5 | 2023 | 603 | 1.050 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 5 | 2024 | 505 | 0.960 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1346 | 0.810 |
Why?
|
Cholangiocarcinoma | 4 | 2023 | 551 | 0.690 |
Why?
|
Sodium Compounds | 1 | 2018 | 35 | 0.650 |
Why?
|
Arsenites | 1 | 2018 | 65 | 0.640 |
Why?
|
Microfilament Proteins | 1 | 2024 | 1133 | 0.630 |
Why?
|
Gallstones | 2 | 2023 | 283 | 0.540 |
Why?
|
Drainage | 3 | 2021 | 1156 | 0.500 |
Why?
|
Endosonography | 1 | 2018 | 607 | 0.480 |
Why?
|
Specimen Handling | 1 | 2018 | 703 | 0.450 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2013 | 136 | 0.420 |
Why?
|
Stents | 6 | 2022 | 3162 | 0.420 |
Why?
|
Republic of Korea | 7 | 2020 | 565 | 0.400 |
Why?
|
Salvage Therapy | 1 | 2018 | 1264 | 0.400 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11709 | 0.390 |
Why?
|
Deoxycytidine | 4 | 2022 | 873 | 0.380 |
Why?
|
Endoscopy | 2 | 2019 | 1832 | 0.350 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3608 | 0.330 |
Why?
|
Adenocarcinoma | 3 | 2022 | 6325 | 0.330 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1051 | 0.330 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1422 | 0.310 |
Why?
|
Spheroids, Cellular | 2 | 2021 | 329 | 0.310 |
Why?
|
Carrier Proteins | 1 | 2021 | 4937 | 0.310 |
Why?
|
Preoperative Care | 1 | 2016 | 2246 | 0.280 |
Why?
|
Survivors | 1 | 2014 | 2370 | 0.220 |
Why?
|
Gene Silencing | 2 | 2021 | 1507 | 0.220 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6469 | 0.220 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2022 | 51 | 0.210 |
Why?
|
Disease-Free Survival | 5 | 2021 | 6808 | 0.210 |
Why?
|
Cholangitis | 1 | 2023 | 111 | 0.210 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 13603 | 0.200 |
Why?
|
Bile Ducts, Intrahepatic | 3 | 2023 | 296 | 0.190 |
Why?
|
CA-19-9 Antigen | 1 | 2021 | 106 | 0.190 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16891 | 0.180 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2023 | 194 | 0.180 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1824 | 0.180 |
Why?
|
Mesenteric Veins | 1 | 2020 | 85 | 0.170 |
Why?
|
Peritoneal Neoplasms | 2 | 2018 | 707 | 0.170 |
Why?
|
Chromogranin A | 1 | 2019 | 49 | 0.170 |
Why?
|
Mice, SCID | 2 | 2021 | 2625 | 0.170 |
Why?
|
Pancreatic Pseudocyst | 1 | 2019 | 110 | 0.160 |
Why?
|
Pancreatitis | 2 | 2018 | 1096 | 0.160 |
Why?
|
Muscle Proteins | 1 | 2024 | 1150 | 0.160 |
Why?
|
Cell Movement | 2 | 2021 | 5201 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 570 | 0.150 |
Why?
|
Portal Vein | 1 | 2020 | 429 | 0.140 |
Why?
|
Leucovorin | 2 | 2020 | 642 | 0.140 |
Why?
|
Gallbladder Neoplasms | 1 | 2018 | 190 | 0.140 |
Why?
|
Biosensing Techniques | 1 | 2023 | 649 | 0.140 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14638 | 0.140 |
Why?
|
Middle Aged | 19 | 2021 | 219219 | 0.130 |
Why?
|
Matrix Metalloproteinases | 1 | 2019 | 392 | 0.130 |
Why?
|
Cell Proliferation | 3 | 2021 | 10416 | 0.130 |
Why?
|
Humans | 37 | 2024 | 757650 | 0.130 |
Why?
|
Prognosis | 10 | 2024 | 29493 | 0.120 |
Why?
|
Metals | 1 | 2019 | 717 | 0.120 |
Why?
|
Male | 21 | 2023 | 358227 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2001 | 0.120 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5815 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2022 | 64242 | 0.120 |
Why?
|
Fluorouracil | 2 | 2020 | 1636 | 0.110 |
Why?
|
Gastric Outlet Obstruction | 1 | 2014 | 54 | 0.110 |
Why?
|
Aged | 14 | 2020 | 167889 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2443 | 0.110 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 406 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 641 | 0.100 |
Why?
|
RNA, Small Interfering | 1 | 2021 | 3432 | 0.100 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2014 | 118 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12400 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2859 | 0.100 |
Why?
|
Female | 20 | 2021 | 389985 | 0.100 |
Why?
|
Gastroesophageal Reflux | 1 | 2019 | 816 | 0.100 |
Why?
|
Anesthesia | 1 | 2023 | 1581 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2023 | 79982 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2201 | 0.090 |
Why?
|
Cisplatin | 1 | 2017 | 1647 | 0.090 |
Why?
|
Decompression, Surgical | 1 | 2016 | 604 | 0.090 |
Why?
|
Camptothecin | 1 | 2014 | 589 | 0.090 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 642 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 3995 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4845 | 0.090 |
Why?
|
Neoplasm Staging | 3 | 2020 | 11083 | 0.090 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2809 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2180 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2021 | 2324 | 0.080 |
Why?
|
Cohort Studies | 6 | 2023 | 41198 | 0.080 |
Why?
|
Quinazolines | 1 | 2014 | 1371 | 0.070 |
Why?
|
Risk Factors | 7 | 2023 | 73716 | 0.070 |
Why?
|
Causality | 1 | 2013 | 1241 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2741 | 0.070 |
Why?
|
Incidence | 3 | 2023 | 21217 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12047 | 0.070 |
Why?
|
Physicians | 1 | 2024 | 4578 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2014 | 817 | 0.060 |
Why?
|
Heart Valve Diseases | 1 | 2013 | 1033 | 0.060 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2024 | 44 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5254 | 0.060 |
Why?
|
Propensity Score | 2 | 2022 | 1887 | 0.050 |
Why?
|
MicroRNAs | 1 | 2019 | 3782 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8505 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8515 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1547 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4313 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9245 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54108 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16533 | 0.050 |
Why?
|
Cholecystectomy | 1 | 2023 | 406 | 0.050 |
Why?
|
Time Factors | 2 | 2020 | 39815 | 0.040 |
Why?
|
Mice | 3 | 2022 | 81107 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3839 | 0.040 |
Why?
|
Karnofsky Performance Status | 1 | 2020 | 165 | 0.040 |
Why?
|
Palliative Care | 3 | 2022 | 3568 | 0.040 |
Why?
|
Mesenteric Arteries | 1 | 2020 | 178 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13265 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20499 | 0.040 |
Why?
|
Comorbidity | 1 | 2013 | 10478 | 0.040 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2023 | 432 | 0.040 |
Why?
|
Catheterization | 1 | 2024 | 1426 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2023 | 641 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4888 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2021 | 979 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1097 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2020 | 999 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2022 | 808 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 549 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8551 | 0.040 |
Why?
|
Laparotomy | 1 | 2019 | 454 | 0.040 |
Why?
|
Animals | 4 | 2022 | 167777 | 0.030 |
Why?
|
Living Donors | 1 | 2021 | 637 | 0.030 |
Why?
|
Motion | 1 | 2019 | 779 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22024 | 0.030 |
Why?
|
Albumins | 1 | 2018 | 575 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12685 | 0.030 |
Why?
|
Nausea | 1 | 2017 | 679 | 0.030 |
Why?
|
Neurotoxicity Syndromes | 1 | 2018 | 300 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13222 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2219 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21990 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13267 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6128 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1727 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1607 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2379 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2021 | 2378 | 0.030 |
Why?
|
Neutropenia | 1 | 2018 | 885 | 0.030 |
Why?
|
Adult | 5 | 2020 | 219747 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3595 | 0.020 |
Why?
|
Hemorrhage | 1 | 2024 | 3399 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1878 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58559 | 0.020 |
Why?
|
Cell Survival | 1 | 2021 | 5782 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
Lipase | 1 | 2013 | 324 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2919 | 0.020 |
Why?
|
Paclitaxel | 1 | 2018 | 1731 | 0.020 |
Why?
|
Norepinephrine | 1 | 2013 | 897 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3613 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9404 | 0.020 |
Why?
|
Postoperative Period | 1 | 2013 | 1806 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2013 | 1093 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10075 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6293 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2018 | 1647 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39018 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3501 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5788 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2105 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9574 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12951 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5951 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7339 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6758 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9624 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2017 | 1923 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7401 | 0.020 |
Why?
|
Models, Statistical | 1 | 2019 | 5068 | 0.010 |
Why?
|
Transcription Factors | 1 | 2024 | 12092 | 0.010 |
Why?
|
Registries | 1 | 2020 | 8164 | 0.010 |
Why?
|
Swine | 1 | 2014 | 5892 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13464 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18328 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7226 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15773 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2013 | 3603 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18123 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36271 | 0.010 |
Why?
|